Gleevec and Conjunctival haemorrhage - from FDA reports


Summary

Conjunctival haemorrhage is found among people who take Gleevec, especially for people who are female, 60+ old , have been taking the drug for 1 - 6 months, also take medication Ambien, and have Chronic myeloid leukaemia . We study 24,728 people who have side effects while taking Gleevec from FDA. Among them, 95 have Conjunctival haemorrhage. Find out below who they are, when they have Conjunctival haemorrhage and more.

What to expect?

If you take Gleevec and have Conjunctival haemorrhage, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Gleevec and have Conjunctival haemorrhage

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Gleevec

Gleevec has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml). (latest outcomes from Gleevec 25,083 users)

Conjunctival Haemorrhage

Conjunctival haemorrhage (bleeding underneath the conjunctiva) has been reported by people with onchocerciasis, atrial fibrillation/flutter, high blood pressure, multiple myeloma, chronic myeloid leukaemia (latest reports from 2,609 Conjunctival haemorrhage patients).

On Feb, 13, 2017

24,728 people reported to have side effects when taking Gleevec.
Among them, 95 people (0.38%) have Conjunctival Haemorrhage


Number of reports submitted per year:

Could Gleevec cause Conjunctival haemorrhage?

Time on Gleevec when people have Conjunctival Haemorrhage *:

  • < 1 month: 17.39 %
  • 1 - 6 months: 34.78 %
  • 6 - 12 months: 21.74 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 4.35 %
  • 5 - 10 years: 21.74 %
  • 10+ years: 0.0 %

Gender of people who have Conjunctival Haemorrhage when taking Gleevec *:

  • female: 78.89 %
  • male: 21.11 %

Age of people who have Conjunctival Haemorrhage when taking Gleevec *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 8.82 %
  • 40-49: 17.65 %
  • 50-59: 16.18 %
  • 60+: 57.35 %

Top conditions involved for these people *:

  • Chronic Myeloid Leukaemia (46 people, 48.42%)
  • Gastrointestinal Stromal Tumor (12 people, 12.63%)
  • Hypothyroidism (4 people, 4.21%)
  • Nausea (3 people, 3.16%)
  • Chronic Myeloid Leukaemia (in Remission) (3 people, 3.16%)

Top co-used drugs for these people *:

  • Lasix (5 people, 5.26%)
  • Folic Acid (5 people, 5.26%)
  • Atenolol (5 people, 5.26%)
  • Ambien (5 people, 5.26%)
  • Klor-Con (4 people, 4.21%)

Top other side effects for these people *:

  • Thrombocytopenia (16 people, 16.84%)
  • Eye Pain (14 people, 14.74%)
  • Rashes (13 people, 13.68%)
  • Fatigue (13 people, 13.68%)
  • Headache (12 people, 12.63%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Conjunctival haemorrhage when taking Gleevec?

Browse all side effects of Gleevec

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Conjunctival haemorrhage

Conjunctival haemorrhage

Could your condition cause Conjunctival haemorrhage

Conjunctival haemorrhage

Related studies

Can you answer these questions?

More questions for: Gleevec, Conjunctival haemorrhage

You may be interested in these reviews

More reviews for: Gleevec, Conjunctival haemorrhage